Repurposing metformin as a potential anticancer agent using in silico technique

Yuruker, Ozel,Kalkan, Rasime

DOI: https://doi.org/10.1007/s40199-024-00523-0

2024-06-26

DARU Journal of Pharmaceutical Sciences

Abstract:The focus on repurposing readily available, well-known drugs for new, creative uses has grown recently. One such medication is metformin, a drug commonly used to manage diabetes, which shows a favorable correlation between its use and lower cancer morbidity and death. Numerous investigations and clinical trials have been conducted to evaluate the possible application of metformin as an anticancer medication in light of this conclusion.

pharmacology & pharmacy

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the effectiveness of metformin as a potential anti - cancer drug through in silico technique. Specifically, the study aims to determine whether metformin is sensitive to specific cancer cell lines, thereby providing a theoretical basis for further using it as an anti - cancer treatment drug.

### Research Background
- **Drug Repurposing**: In recent years, drug repurposing has become a research hotspot, that is, using known drugs for new purposes. Metformin is a commonly used diabetes drug, and previous studies have shown that its use is associated with lower cancer incidence and mortality.
- **Anti - cancer Potential**: Multiple studies and clinical trials have evaluated the potential of metformin as an anti - cancer drug, but its specific mechanisms and targets still need further exploration.

### Research Objectives
- **Gene - drug Interaction Analysis**: Through "pathway/gene - set analysis" and Gene2drug resources, combined with Gene Ontology (GO) and DepMap data, determine the sensitivity of metformin in specific cancer cell lines.
- **Screening Sensitive Genes**: Through drug sensitivity analysis of 1,826 tumor cell lines, screen out genes that are sensitive to metformin.

### Methods
- **Data Sources**: Use Drug Set Enrichment Analysis (DSEA) and Gene2drug resources to analyze 1,826 cancer cell lines based on the PRISM viability assay.
- **Gene - drug Interaction Analysis**: Evaluate the anti - tumor activity of metformin and its target genes through DepMap data.
- **Statistical Analysis**: Use the criterion of P - value less than 1E - 2 to screen out significantly sensitive genes.

### Results
- **Sensitive Genes**: Among the 1,826 cancer cell lines, a total of 9 genes sensitive to metformin were screened out: SGPL1, CXCR6, ATXN2L, LAMP3, RTN3, BTN2A1, FOXM1, NQO1 and L1TD1.
- **Specific Sensitivity**: These genes show significant sensitivity in different types of cancer cell lines, such as bladder urothelial carcinoma, colorectal adenocarcinoma, endometrial cancer, etc.

### Discussion
- **Gene Functions**:
- **SGPL1**: Participates in sphingolipid and fatty acid metabolism, and high concentrations of S1P are related to the development of cancer cells and chemotherapy resistance.
- **CXCR6**: Participates in the migration and localization of T lymphocytes and may play a promoting or inhibiting role in tumor growth.
- **ATXN2L**: Is over - expressed in tumor tissues and may be related to chemotherapy resistance.
- **LAMP3**: Is over - expressed in multiple cancer types and is associated with tumor spread and poor prognosis.
- **RTN3**: Is usually low - expressed in liver cancer cells, and low - expression is related to TP53 gene mutations.
- **BTN2A1**: Participates in the metabolism of cholesterol, fatty acids and lipids, and high - expression is related to a better chemotherapy response.
- **FOXM1**: Promotes cell cycle progression and proliferation and is over - expressed in multiple cancers.
- **NQO1**: Prevents quinones from generating free radicals, and its mutations are related to cancer susceptibility.
- **L1TD1**: Is low - expressed in non - small - cell lung cancer cell lines, and over - expression can reduce the survival and proliferation ability of tumor cells.

### Conclusions
- **Research Significance**: This study screened out genes sensitive to metformin through in silico technique, providing theoretical support for metformin as a potential anti - cancer drug.
- **Future Directions**: Further experimental verification, such as cell culture and animal experiments, is required to confirm the sensitivity of these genes to metformin and their mechanism of action in cancer treatment.

### Formula Examples
- **P - value**: $P < 1E^{-2}$
- **AUC**: $AUC=\text{Area Under the Curve}$

This study provides a new perspective on the application of metformin in cancer treatment, but more experimental verification and clinical trials are still needed to further confirm its effects and mechanisms.